perfluorobutane has been researched along with Cirrhosis, Liver in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, K; Jeong, WK; Lee, JY; Lee, KH; Lee, SJ; Nam, CM; Park, JH; Park, MJ; Park, MS; Park, SH | 1 |
| Amanuma, M; Daido, Y; Igarashi, Y; Kobayashi, K; Kudo, T; Maruyama, K; Matsui, D; Matsui, T; Matsukiyo, Y; Momiyama, K; Mukozu, T; Nagai, H; Ogino, Y; Shinohara, M; Sumino, Y; Wakui, N; Yoshimine, N | 1 |
| Baliff, JP; Brown, DB; Chalek, CL; Dave, JK; Dianis, S; Eisenbrey, JR; Forsberg, F; Gonzalez, JM; Halldorsdottir, VG; Kim, CE; Machado, P; Merton, DA; Miller, C; Navarro, V; Park, S; Thomenius, KE | 1 |
| Akasu, G; Goto, Y; Kinoshita, H; Okuda, K; Tanaka, H | 1 |
| Cho, J; Kang, M; Kim, KW; Kwon, H; Lee, S; Lee, SW; Park, J; Roh, YH | 1 |
| Imai, Y; Moriyasu, F; Sugimoto, K; Yoshiyuki, K | 1 |
| Lee, HS | 1 |
| Shiozawa, K; Sumino, Y; Watanabe, M | 1 |
| Hashimoto, T; Hiraishi, H; Kojima, K; Maeda, C; Tamano, M | 1 |
| Doi, K; Ichimura, S; Metoki, R; Moriyasu, F; Shiraishi, J; Sugimoto, K | 1 |
| Fujiwara, K; Imazeki, F; Ishibashi, H; Kamesaki, H; Maruyama, H; Shimada, T; Takahashi, M; Yokosuka, O | 1 |
| Kamesaki, H; Kanai, F; Maruyama, H; Sekimoto, T; Shimada, T; Takahashi, M; Yokosuka, O | 1 |
| Maruyama, H; Shimada, T; Takahashi, M; Yokosuka, O | 1 |
| Barr, RG; Chammas, MC; Chaubal, NG; Chen, MH; Choi, BI; Claudon, M; Clevert, DA; Correas, JM; Cosgrove, DO; Dietrich, CF; Ding, H; Forsberg, F; Fowlkes, JB; Gibson, RN; Goldberg, BB; Kudo, M; Lassau, N; Leen, EL; Mattrey, RF; Moriyasu, F; Nolsøe, CP; Piscaglia, F; Solbiati, L; Weskott, HP; Wilson, SR; Xu, HX | 1 |
| Blomley, MJ; Cosgrove, DO; Gedroyc, WM; Harvey, CJ; Lim, AK; Taylor-Robinson, SD | 1 |
| Ji, Q; Lin, MX; Liu, GJ; Lu, MD; Moriyasu, F; Wang, W; Wong, LH; Xie, XY | 1 |
| Ishibashi, H; Kiyono, S; Kondo, T; Maruyama, H; Sekimoto, T; Shimada, T; Takahashi, M; Yamaguchi, T; Yokosuka, O | 1 |
3 trial(s) available for perfluorobutane and Cirrhosis, Liver
| Article | Year |
|---|---|
Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cross-Sectional Studies; Early Detection of Cancer; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Oxides; Research Design; Ultrasonography; Young Adult | 2017 |
Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis.
Topics: Aged; Contrast Media; Feasibility Studies; Female; Ferric Compounds; Fluorocarbons; Humans; Image Interpretation, Computer-Assisted; Iron; Liver Cirrhosis; Microbubbles; Middle Aged; Oxides; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Ultrasonography; Young Adult | 2012 |
Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding.
Topics: Acute Disease; Aged; Anticoagulants; Contrast Media; Emergencies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Ferric Compounds; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemostatic Techniques; Heparin, Low-Molecular-Weight; Humans; Iron; Ligation; Liver Cirrhosis; Male; Middle Aged; Oxides; Pilot Projects; Portal Vein; Prospective Studies; Thrombosis; Treatment Outcome; Ultrasonography | 2012 |
14 other study(ies) available for perfluorobutane and Cirrhosis, Liver
| Article | Year |
|---|---|
Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver Disease.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Disease Progression; Female; Ferric Compounds; Hepatitis C, Chronic; Humans; Image Enhancement; Iron; Liver; Liver Cirrhosis; Male; Microbubbles; Middle Aged; Oxides; ROC Curve; Severity of Illness Index; Ultrasonography; Young Adult | 2019 |
Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient.
Topics: Adult; Aged; Biopsy; Chronic Disease; Contrast Media; Female; Ferric Compounds; Hepatic Veins; Humans; Hypertension, Portal; Iron; Liver Cirrhosis; Male; Middle Aged; Oxides; Pilot Projects; ROC Curve; Sensitivity and Specificity; Ultrasonography, Interventional | 2013 |
Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Ferric Compounds; Hepatic Artery; Hepatic Veins; Humans; Iron; Liver Cirrhosis; Male; Middle Aged; Oxides; Portal Vein; Sensitivity and Specificity; Ultrasonography | 2014 |
Liver Function Assessment Using Parenchyma-Specific Contrast-Enhanced Ultrasonography.
Topics: Aged; Aged, 80 and over; Computer Simulation; Contrast Media; Female; Ferric Compounds; Humans; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Oxides; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2016 |
Assessment of irreversible electroporation ablation zone using Kupffer-phase contrast-enhanced ultrasound images with Sonazoid.
Topics: Ablation Techniques; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Electroporation; Ferric Compounds; Gadolinium DTPA; Hepatitis C; Humans; Iron; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Oxides; Tomography, X-Ray Computed; Ultrasonography, Interventional | 2014 |
New diagnostic tools of hepatitis virus-related liver diseases. Preface.
Topics: Antiviral Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Diagnosis, Differential; Drug Resistance, Viral; Elasticity Imaging Techniques; Ferric Compounds; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Iron; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Oxides; Tomography, X-Ray Computed | 2008 |
Evaluation of the hemodynamic status of focal hepatic lesions 20 mm or less in diameter by contrast-enhanced ultrasonography using Sonazoid.
Topics: Aged; Female; Ferric Compounds; Hemodynamics; Hepatitis C, Chronic; Humans; Iron; Liver; Liver Cirrhosis; Male; Middle Aged; Oxides; Ultrasonography | 2009 |
Diagnosis of hepatic hydrothorax using contrast-enhanced ultrasonography with intraperitoneal injection of Sonazoid.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Ferric Compounds; Humans; Hydrothorax; Injections, Intraperitoneal; Iron; Liver Cirrhosis; Male; Middle Aged; Oxides; Peritoneal Cavity; Pleural Cavity; Predictive Value of Tests; Ultrasonography | 2010 |
Analysis of intrahepatic vascular morphological changes of chronic liver disease for assessment of liver fibrosis stages by micro-flow imaging with contrast-enhanced ultrasound: preliminary experience.
Topics: Adult; Biopsy, Needle; Chronic Disease; Contrast Media; Female; Ferric Compounds; Humans; Iron; Liver; Liver Cirrhosis; Male; Middle Aged; Oxides; Portal Vein; Reproducibility of Results; Ultrasonography | 2010 |
Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Iron; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Male; Metabolic Clearance Rate; Microbubbles; Middle Aged; Oxides; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Ultrasonography | 2012 |
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.
Topics: Anaphylaxis; Biopsy, Needle; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contraindications; Contrast Media; Diagnosis, Differential; Drug Hypersensitivity; Drug Interactions; Ferric Compounds; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Liver Transplantation; Oxides; Phospholipids; Risk Factors; Sulfur Hexafluoride; Ultrasonography, Doppler; Ultrasonography, Interventional | 2013 |
Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Unknown Primary; Oxides; Sensitivity and Specificity; Ultrasonography, Interventional | 2002 |
Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats.
Topics: Animals; Contrast Media; Fluorocarbons; Liver; Liver Cirrhosis; Male; Microbubbles; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Spleen; Ultrasonography | 2013 |
Hepatic filling rate of a microbubble agent: a novel predictor of long-term outcomes in patients with cirrhosis.
Topics: Adult; Aged; Contrast Media; Female; Fluorocarbons; Follow-Up Studies; Hepatic Artery; Humans; Image Enhancement; Liver; Liver Cirrhosis; Male; Microbubbles; Middle Aged; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Ultrasonography | 2014 |